M06.20 Rheumatoid bursitis, unspecified site

Name of the Condition

• Rheumatoid bursitis, unspecified site

Summary

Rheumatoid bursitis is a condition characterized by inflammation of the bursae (fluid-filled sacs that cushion joints) due to rheumatoid arthritis (RA). It occurs when the immune system’s inflammatory processes affect these protective structures, leading to pain, swelling, and limited mobility. The term "unspecified site" indicates the bursitis is not localized to a particular joint or area. Diagnosis requires correlation of clinical findings with RA history or serologic evidence.

Causes

Rheumatoid bursitis arises from the chronic inflammatory processes of rheumatoid arthritis. The immune system’s attack on joint tissues extends to bursae, causing fluid accumulation and irritation. While RA is the primary driver, mechanical stress or trauma to bursae may exacerbate inflammation in susceptible individuals.

Risk Factors

• Preexisting rheumatoid arthritis, increasing bursal inflammation risk.
• Advanced age, as RA severity often progresses over time.
• Prolonged joint overuse or pressure, which may irritate bursae.
• Systemic inflammation, as seen in active RA flares.

Symptoms

• Localized swelling and tenderness over affected bursae.
• Pain with movement or pressure on the inflamed area.
• Reduced range of motion in adjacent joints.
• Warmth or redness (if inflammation is acute).
• Possible stiffness, especially after periods of inactivity.

Diagnosis

Diagnosis involves clinical evaluation of bursal swelling, tenderness, and mobility limitations, combined with a history of rheumatoid arthritis. Imaging (e.g., ultrasound) may confirm fluid accumulation, while blood tests (e.g., inflammatory markers) support RA activity. Exclusion of infectious or traumatic bursitis is essential.

Treatment Options

• Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation.
• Corticosteroid injections for localized, severe symptoms.
• Disease-modifying antirheumatic drugs (DMARDs) to control underlying RA.
• Physical therapy to maintain joint function and reduce stress on bursae.
• Rest and activity modification to avoid aggravating movements.

Prognosis and Follow-Up

Prognosis depends on RA control; effective management of systemic inflammation often improves bursal symptoms. Flares may occur with RA exacerbations. Regular follow-up with a rheumatologist ensures timely adjustment of therapies and monitoring for joint damage.

Complications

• Chronic bursal inflammation leading to fibrosis or reduced mobility.
• Secondary infection if bursal fluid becomes contaminated.
• Persistent pain or functional impairment if untreated.
• Spread of inflammation to adjacent tissues in severe RA cases.

Lifestyle & Prevention

• Maintain joint-friendly activities to reduce bursal stress.
• Use ergonomic supports (e.g., cushions, braces) for repetitive movements.
• Follow RA treatment plans to minimize systemic inflammation.
• Apply ice packs to inflamed areas during flares (if advised by a provider).

When to Seek Professional Help

Seek care if bursal swelling is severe, worsening, or accompanied by fever (suggesting infection), or if mobility declines significantly. Prompt evaluation is needed if symptoms do not improve with rest or over-the-counter measures.

Tips for Medical Coders

Document the site of bursitis if known, as unspecified sites use M06.20. Confirm RA diagnosis or serologic evidence to support rheumatoid etiology. Differentiate from other bursal conditions (e.g., traumatic or infectious) to ensure accurate coding.